These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 8723013)

  • 21. Pharmacology of platelet-inhibitory drugs, anticoagulants, and thrombolytic agents.
    Mehta JL; Kitchens CS
    Cardiovasc Clin; 1987; 18(1):163-79. PubMed ID: 3111692
    [No Abstract]   [Full Text] [Related]  

  • 22. Mode of action and pharmacology of saruplase.
    Vermeer F
    Int J Clin Pract Suppl; 1998 Nov; 99():6-8. PubMed ID: 10344034
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of thrombolytic therapy on recanalization in different starting time of treatment after acute myocardial infarction.
    Shen L; Yang J; Hu Q; Teng Y; Han X; Yan S; Lian M; Xie M; Gu F
    Chin Med J (Engl); 1997 Jan; 110(1):53-5. PubMed ID: 9594323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful thrombolysis of inferior vena cava thrombolysis in a preterm neonate.
    Häusler M; Hübner D; Hörnchen H; Mühler EG; Merz U
    Clin Pediatr (Phila); 2001 Feb; 40(2):105-8. PubMed ID: 11261446
    [No Abstract]   [Full Text] [Related]  

  • 25. Pulse-spray pharmacomechanical thrombolysis for proximal deep vein thrombosis.
    Elsharawy MA
    Eur J Vasc Endovasc Surg; 2006 Nov; 32(5):604; author reply 604-5. PubMed ID: 16928456
    [No Abstract]   [Full Text] [Related]  

  • 26. Failure of thrombolytic therapy in four children with extensive thromboses.
    Ryan CA; Andrew M
    Am J Dis Child; 1992 Feb; 146(2):187-93. PubMed ID: 1733148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacological potentials for activating the fibrinolytic system].
    Markwardt F
    Z Gesamte Inn Med; 1984 May; 39(10):209-13. PubMed ID: 6380126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrinolytic agents.
    Schmitz-Huebner U; van de Loo J
    Clin Haematol; 1981 Jun; 10(2):481-96. PubMed ID: 7032785
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular mechanisms of thrombolysis: implications for therapy.
    Collen D; Lijnen HR
    Biochem Pharmacol; 1990 Jul; 40(2):177-86. PubMed ID: 2115776
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pharmacology of fibrinolytics].
    Klöcking HP
    Z Gesamte Inn Med; 1979 Jan; 34(1):22-8. PubMed ID: 373275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombolysis in interventional radiology.
    Sattler S
    Radiol Technol; 1995; 66(4):259-60. PubMed ID: 7784549
    [No Abstract]   [Full Text] [Related]  

  • 32. Thrombolytic agents.
    Thompson PL
    Med J Aust; 1994 Jan; 160(1):29-32. PubMed ID: 8271981
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical use of thrombolytic agents].
    Laprevote-Heully MC; Lambert H; Larcan A
    Agressologie; 1983 Nov; 24(11):559-65. PubMed ID: 6367511
    [No Abstract]   [Full Text] [Related]  

  • 34. [Thrombolytic therapy in cerebrovascular disease].
    Alvaro LC; Sádaba F
    Neurologia; 1993 Mar; 8(3):110-21. PubMed ID: 8448041
    [No Abstract]   [Full Text] [Related]  

  • 35. Current status of thrombolysis.
    Sell JJ; Rupp FW; Telepak RJ
    West J Med; 1996; 165(1-2):53. PubMed ID: 8855686
    [No Abstract]   [Full Text] [Related]  

  • 36. [Thrombolytic treatment of deep venous thrombosis].
    Martínez-Brotons F; Cairols MA
    Sangre (Barc); 1984; 29(4-C):762-6. PubMed ID: 6515512
    [No Abstract]   [Full Text] [Related]  

  • 37. [Behavior of postoperative adhesions after intraperitoneal administration of fibrinolytic drugs in a rat model].
    Stapel A; Geissler N; Mlasowsky B; Jung D
    Langenbecks Arch Chir; 1997; 382(1):33-6. PubMed ID: 9157230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiplatelet effect of FK633, a platelet glycoprotein IIb/IIIa antagonist, on thrombus formation and vascular patency after thrombolysis in the injured hamster carotid artery.
    Kaida T; Matsuno H; Niwa M; Kozawa O; Miyata H; Uematsu T
    Thromb Haemost; 1997 Mar; 77(3):562-7. PubMed ID: 9066011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time course of platelet aggregation during thrombolytic treatment of massive pulmonary embolism.
    Mühl D; Füredi R; Gecse K; Ghosh S; Falusi B; Bogár L; Roth E; Lantos J
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):661-7. PubMed ID: 17890954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Synthetic compounds with fibrinolytic and thrombolytic activity. I. Pharmacologic observations].
    Desnoyers P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):351-6. PubMed ID: 63421
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.